appScorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Shukra Pharmaceuticals Ltd
SHUKRAPHAR
Price Chart
Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Shukra Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceuticals Products.
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Company Update
Shukra Pharmaceuticals Ltd - 524632 - Announcement Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015 ('SEBI LODR") For Intimation For Receipt Of In- Principal Approval From Stock Exchange Under Regulation 28(1) Of SEBI LODR | Download
Shukra Pharmaceuticals Ltd - 524632 - Announcement Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015 ('SEBI LODR") For Intimation For Receipt Of In- Principal Approval From Stock Exchange Under Regulation 28(1) Of SEBI LODR | Download
Cash Dividend
Final • Div/Share: ₹ 1
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant